# Trial of Written Exposure for Metastatic Cancer Patients (EASE)

> **NCT06042400** · NA · COMPLETED · sponsor: **University of Colorado, Boulder** · enrollment: 30 (actual)

## Conditions studied

- Metastatic Cancer
- Solid Tumor Cancer
- Lymphoproliferative Disorders
- Anxiety
- Post-traumatic Stress Symptoms
- Fear of Cancer Progression

## Interventions

- **BEHAVIORAL:** Written Exposure Therapy

## Key facts

- **NCT ID:** NCT06042400
- **Lead sponsor:** University of Colorado, Boulder
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-18
- **Primary completion:** 2023-09-21
- **Final completion:** 2023-09-21
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06042400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06042400, "Trial of Written Exposure for Metastatic Cancer Patients (EASE)". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT06042400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*